Glasdegib is a medication that belongs to a class of drugs known as hedgehog pathway inhibitors. It is primarily used in the treatment of certain types of blood cancers, specifically acute myeloid leukemia (AML) in adults who are not candidates for intensive chemotherapy.

This medication works by blocking a specific pathway in cancer cells, which helps to slow down the growth and spread of the cancer. It is typically taken in combination with other chemotherapy medications to improve the overall effectiveness of treatment.

As with any medication, there are potential side effects associated with glasdegib. These can include nausea, diarrhea, fatigue, and changes in blood cell counts. It is important to discuss any potential side effects with your healthcare provider and report any new or worsening symptoms while taking this medication.

It is crucial to follow your healthcare provider’s instructions carefully when taking glasdegib. This includes taking the medication at the same time each day, as well as following any dietary or lifestyle recommendations that may be provided.

If you have any questions or concerns about glasdegib or its potential benefits and risks, do not hesitate to speak with your healthcare provider. They can provide you with more information and guidance on how to best manage your treatment plan.

Overall, glasdegib is a valuable medication in the treatment of certain types of blood cancers, and when used appropriately under the guidance of a healthcare provider, it can help improve outcomes for patients.